Published online before print April 6, 2006, doi: 10.1161/01.STR.0000217653.01615.93
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2006;37:1165.)
© 2006 American Heart Association, Inc.
Original Contributions |
Reducing the Risk of Dementia
Efficacy of Long-Term Treatment of Hypertension
From the Laboratory of Epidemiology (R.P., L.J.L.), Demography and Biometry, National Institute on Aging, National Institutes of Health, Bethesda, MD; the Pacific Health Research Institute (R.P., L.W., K.M., H.P.), Honolulu, Hawai; and the Department of Geriatric Medicine (L.W., K.M., H.P.), John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawai.
Correspondence and reprint requests to Rita Peila, Laboratory of Epidemiology, Demography and Biometry, National Institute on Aging, National Institutes of Health, Room 3C-309 Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892, USA. E-mail peilar{at}mail.nih.gov
Background and Purpose— The efficacy of treating older persons for hypertension remains controversial. Although clinical trials suggest no short-term harm, or some benefits, there are little data on the effect on cognitive function of long-term antihypertensive treatment. We evaluated the risk of dementia and cognitive decline associated with duration of antihypertensive treatment.
Methods— Data are from the Honolulu Asia Aging Study on Japanese American men followed since 1965. The subjects included in this analysis were hypertensive from midlife and dementia-free in 1991 (mean age 76.7 years). In 1991, 1994 and 1997, global cognitive function was assessed with the Cognitive Abilities Screening Instrument (CASI) and dementia by a standardized examination using international criteria. The sample was grouped by treatment duration (never-treated hypertensives (NTH), <5 years, 5 to 12 years, >12 years). Normotensive subjects up to 1991 were included in the analysis as a control group.
Results— For each additional year of treatment there was a reduction in the risk of incident dementia (hazard ratio [HR]=0.94, 95% CI, 0.89 to 0.99). The risk for dementia in subjects with >12 years of treatment was lower compared to NTH (HR for dementia=0.40; 95% CI, 0.22 to 0.75 and for Alzheimer disease HR=0.35; 95% CI, 0.16 to 0.78) and was similar to the normotensives. Nondemented subjects with 5 to 12 years of treatment had lower yearly CASI decline compared to NTH.
Conclusions— Results suggest that in hypertensive men, the duration of the antihypertensive treatment is associated with a reduced risk for dementia and cognitive decline.
Key Words: dementia • hypertension • treatment
Related Article:
Stroke 2006 37: 1146.
This article has been cited by other articles:
 |
|
 |
|
  B. Williams The year in hypertension. J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1803 - 1817. [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Chobanian Isolated Systolic Hypertension in the Elderly N. Engl. J. Med., August 23, 2007; 357(8): 789 - 796. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Staessen, T. Richart, and W. H. Birkenhager Less Atherosclerosis and Lower Blood Pressure for a Meaningful Life Perspective With More Brain Hypertension, March 1, 2007; 49(3): 389 - 400. [Full Text] [PDF]
|
|
|
|
 |
|
 J. V. Bowler and P. B. Gorelick Advances in Vascular Cognitive Impairment 2006 Stroke, February 1, 2007; 38(2): 241 - 244. [Full Text] [PDF]
|
|
|
|
|
|
D. Hadjiev and P. Mineva Antihypertensive Treatment in Reducing the Risk of Dementia Stroke, December 1, 2006; 37(12): 2869 - 2869. [Full Text] [PDF]
|
|
|
|
 |
|
 Treat Hypertension, Prevent Dementia? Journal Watch Neurology, August 1, 2006; 2006(801): 3 - 3. [Full Text]
|
|
|
|
 |
|
 Can Treating Hypertension Lower the Risk for Dementia? Journal Watch Cardiology, May 18, 2006; 2006(518): 5 - 5. [Full Text]
|
|